RAPILIFE 8 10 S

About

Rapilife 8 contains Silodosin, a highly selective alpha-1A adrenergic receptor antagonist used for the treatment of benign prostatic hyperplasia (BPH). Silodosin works by relaxing the smooth muscles in the prostate, bladder neck, and urethra, which are rich in alpha-1A receptors. This relaxation reduces the obstruction to urine flow, thereby improving urinary symptoms such as weak stream, hesitancy, urgency, and incomplete bladder emptying associated with BPH. Its high selectivity for alpha-1A receptors means it has a lower propensity to cause systemic blood pressure changes compared to less selective alpha-blockers.

The medication provides rapid symptomatic relief by addressing the dynamic component of BPH, which is the increased muscle tone. By facilitating easier passage of urine, Silodosin significantly enhances the quality of life for men suffering from BPH symptoms. It is important to adhere to the prescribed dosage and administration instructions to maximize efficacy and minimize potential adverse effects.

Uses

• Relief of symptoms of benign prostatic hyperplasia (BPH)
• Improvement of urinary flow in men with BPH
• Reduction of urinary frequency and urgency
• Alleviation of incomplete bladder emptying

Directions For Use

Take orally, once daily, with a meal. Swallow the tablet whole; do not crush or chew.

Benefits

• Highly selective action on prostate receptors
• Effective relief of BPH symptoms
• Significant improvement in urinary flow
• Reduces nocturia and urinary urgency
• Potentially lower risk of orthostatic hypotension
• Convenient once-daily dosing

Side Effects

• Retrograde ejaculation
• Dizziness
• Orthostatic hypotension
• Headache
• Diarrhea
• Nasal congestion
• Syncope
• Asthenia
• Insomnia
• Dry mouth
• Blurred vision
• Priapism (rare)

Safety Measures

• Alcohol - Alcohol may increase the risk of dizziness and orthostatic hypotension when taken with Silodosin. It is advisable to avoid or limit alcohol consumption.
• Pregnancy - Silodosin is not indicated for use in women.
• Breastfeeding - Silodosin is not indicated for use in women.
• Liver - Use with caution in patients with mild to moderate hepatic impairment. Not recommended in severe hepatic impairment.
• Kidney - Dose adjustment is required in moderate renal impairment (CrCl 30-50 mL/min). Contraindicated in severe renal impairment (CrCl < 30 mL/min).
• Lung - Generally safe for use in patients with lung conditions, but caution is advised if there's a risk of syncope that could exacerbate a pre-existing respiratory issue.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.